Vnitr Lek 2010, 56(5):418-426

The heart of a patient with type 1 diabetes

S. Lacigová*, J. Meinlová, J. Gruberová
I. interní klinika Lékařské fakulty UK a FN Plzeň, přednosta prof. MUDr. Martin Matějovič, Ph.D.

The heart of a patient with type 1 diabetes might be affected by ischemic heart disease, cardiovascular autonomic neuropathy as well as diabetic cardiomyopathy. These diseases might occur in isolation, although, more frequently, their effects are combined. Also, these co-morbidities have common risk factors. The aim of this review paper is to summarise the options currently available for the diagnostics, prevention and treatment of the listed heart diseases and, since the most frequent cause of death in the type 1 diabetes patients are cardiovascular diseases, to emphasise the fact that these patients should have cardiology assessment. To ensure clarity of the paper, each disease is discussed in a separate chapter.

Keywords: type 1 diabetes mellitus; ischemic heart disease; cardiovascular autoimmune neuropathy; diabetic cardiomyopathy

Received: October 20, 2009; Accepted: February 23, 2010; Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lacigová S, Meinlová J, Gruberová J. The heart of a patient with type 1 diabetes. Vnitr Lek. 2010;56(5):418-426.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Soedamah-Muthu SS, Fuller JH, Mulnier HE et al. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 2006; 49: 660-666. Go to original source... Go to PubMed...
    2. Libby P, Nathan DM, Abraham K et al. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. Circulation 2005; 111: 3489-3493. Go to original source... Go to PubMed...
    3. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis; epidemiology, pathophysiology, and management. JAMA 2002; 287: 2570-2581. Go to original source... Go to PubMed...
    4. Strong JP, Malcom GT, McMahan CA et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implication for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 1999; 281: 727-735. Go to original source... Go to PubMed...
    5. Orchard TJ, Costacou T, Kretowski A et al. Type 1 diabetes and coronary artery disease. Diabetes Care 2006; 29: 2528-2538. Go to original source... Go to PubMed...
    6. Pambianco G, Costacou T, Ellis D et al. The 30-year natural history of type 1 diabetes complication: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006; 55: 1463-1469. Go to original source... Go to PubMed...
    7. Dahl-Jørgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia 2005; 48: 1445-1453. Go to original source... Go to PubMed...
    8. Järvisalo MJ, Jartti J, Näntö-Salonen K et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001; 104: 2943-2947. Go to original source... Go to PubMed...
    9. Margeirsdottir HD, Larsen JR, Brunborg C et al. Norwegian Study Group for Childhood Diabetes. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia 2008; 51: 554-561. Go to original source... Go to PubMed...
    10. Schwab KO, Doerfer J, Hecker W et al. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care 2006; 29: 218-225. Go to original source... Go to PubMed...
    11. Laing SP, Swerdlow AJ, Slater SD et al. Mortality from heart disease in cohort of 23 000 patients with insulin-treated diabetes. Diabetologia 2003; 46: 760-765. Go to original source... Go to PubMed...
    12. Larsen J, Brekke M, Sandvik L et al. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 2002; 51: 2637-2641. Go to original source... Go to PubMed...
    13. Pajunen P, Taskinen MR, Nieminen MS et al. Angiographic severity and extent of coronary disease in patients with type 1 diabetes mellitus. Am J Cardiol 2000; 86: 1080-1085. Go to original source... Go to PubMed...
    14. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986. Go to original source... Go to PubMed...
    15. Nathan DM, Lachin J, Cleary P et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 2003; 348: 2294-2303. Go to original source... Go to PubMed...
    16. Nahtan DM, Cleary PA, Backlund JY et al. DCCT/EDIC study research group. Intensive diabetes treatment and cardiovascular disease in patients with Type 1 Diabetes. N Engl J Med 2005; 353: 2643-2653. Go to original source... Go to PubMed...
    17. Larsen JR, Brekke M, Bergengen L et al. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia 2005; 48: 776-779. Go to original source... Go to PubMed...
    18. Jensen-Urstad KJ, Reichard PG, Rosfors JS et al. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 1996; 45: 1253-1258. Go to original source... Go to PubMed...
    19. Stettler C, Allemann S, Jüni P et al. Glycemic control and macrovascular disease in type 1 and 2 diabetes mellitus: meta-analysis and of randomized trials. Am Heart J 2006; 152: 27-38. Go to original source... Go to PubMed...
    20. Orchard TJ, Olson JC, Erbey JR et al. Insulin resistance - related factors but not glycemia, predict coronary artery disease in type 1 diabetes: 10 year follow-up data from the Pittsburg Epidemiology of Diabetes Complication Study. Diabetes Care 2003; 26: 1374-1379. Go to original source... Go to PubMed...
    21. Prince CT, Becker DJ, Costacou T et al. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia 2007; 50: 2280-2288. Go to original source... Go to PubMed...
    22. Juutilainen A, Lehto S, Rönnemma T et al. Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 2008; 31: 714-719. Go to original source... Go to PubMed...
    23. Orchard TJ, Stevens LK, Forrest KY et al. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. Int J Epidemiol 1998; 27: 976-983. Go to original source... Go to PubMed...
    24. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (Suppl 2): 555-576. Go to PubMed...
    25. Erbey JR, Kuller LH, Becker DJ et al. The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 1998; 21: 610-614. Go to original source... Go to PubMed...
    26. Mäkimattila S, Ylitalo K, Schlenzka A et al. Family histories of Type II. diabetes and hypertension predict intima-media thickness in patients with Type I diabetes. Diabetologia 2002; 45: 711-718. Go to original source... Go to PubMed...
    27. Thorn LM, Forsblom C, Fagerudd J et al. FinnDiane Study Group. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (The FinnDiane study). Diabetes Care 2005; 28: 2019-2024. Go to original source... Go to PubMed...
    28. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome and complication risk in type 1 diabetes. "Double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care 2007; 30: 707-712. Go to original source... Go to PubMed...
    29. Lloyd CE, Kuller LH, Ellis D et al. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Arterioscler Thromb Vasc Biol 1996; 16: 720-726. Go to original source... Go to PubMed...
    30. Taskinen MR. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992; 41 (Suppl 2): 12-17. Go to original source... Go to PubMed...
    31. Jenkins AJ, Lyons TJ, Zheng D et al. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: association with gender and glycemia. Diabetes Care 2003; 26: 810-818. Go to original source... Go to PubMed...
    32. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143. Go to original source... Go to PubMed...
    33. Groop PH, Thomas MC, Rosengård-Bärlund M et al. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care 2007; 30: 2706-2707. Go to original source... Go to PubMed...
    34. Tuomilehto J, Borch-Johnsen K, Molarius A et al. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 1998; 41: 784-790. Go to original source... Go to PubMed...
    35. Torffvit O, Lövestam-Adrian M, Agardh E et al. Nephropathy, but not retinopathy is associated with the development of heart disease in type 1 diabetes: a 12-year observation study of 462 patients. Diabet Med 2005; 22: 723-729. Go to original source... Go to PubMed...
    36. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653. Go to original source... Go to PubMed...
    37. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32-35. Go to original source... Go to PubMed...
    38. Whincup PH, Gilg JA, Emberson JR et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with nicotine measurement. BMJ 2004; 329: 200-205. Go to original source... Go to PubMed...
    39. Robinson RT, Harris ND, Ireland RH et al. Changes in cardiac repolarization during clinical episodes of nocturnal hypoglycaemia in adults with Type 1 diabetes. Diabetologia 2004; 47: 312-315. Go to original source... Go to PubMed...
    40. Duh E, Feinglos M. Hypoglycemia-induced angina pectoris in a patient with diabetes mellitus. Ann Intern Med 1994; 121: 945-946. Go to original source... Go to PubMed...
    41. Järvisalo MJ, Raitakari M, Toikka JO et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004; 109: 1750-1755. Go to original source... Go to PubMed...
    42. Haller MJ, Samyn M, Nichols WW et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care 2004; 27: 2911-2917. Go to original source... Go to PubMed...
    43. Dabelea D, Kinney G, Snell-Bergeon JK et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes 2003; 52: 2833-2839. Go to original source... Go to PubMed...
    44. Janowitz WR, Agatston AS, Kaplan G et al. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol 1993; 72: 247-254. Go to original source... Go to PubMed...
    45. Costacou T, Edmundowicz D, Prince C et al. Progression of coronary artery calcium in type 1 diabetes mellitus. Am J Cardiol 2007; 100: 1543-1547. Go to original source... Go to PubMed...
    46. Bax JJ, Young LH, Frye RL et al. Screening for coronary Artery disease in patients with diabetes. Diabetes Care 2007; 30: 2729-2736. Go to original source... Go to PubMed...
    47. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28 (Suppl 1): S4-S36. Go to original source... Go to PubMed...
    48. McGill HC Jr, McMahan CA. Starting earlier to prevent heart disease. JAMA 2003; 290: 2320-2322. Go to original source... Go to PubMed...
    49. Colwell JA. American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care 2003; 26 (Suppl 1): S87-S88. Go to original source... Go to PubMed...
    50. Barclav L. American Diabetes Association revises diabetes guidelines. Medscape CME. Diabetes Care December 2009: ahead of pub; prepared for publication in January 2010.
    51. Moy CS, Songer TJ, LaPorte RE et al. Insulin-dependent diabetes mellitus, physical activity, and death. Am J Epidemiol 1993; 137: 74-81. Go to original source... Go to PubMed...
    52. Khan AS, McLoughney CR, Ahmed AB. The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes. Diabet Med 2006; 23: 1079-1084. Go to original source... Go to PubMed...
    53. Nathan DM, Clary PA, Backlund JYC et al. Intensive diabetes treatment and cardiovascular disease in patients with 1 diabetes. N Engl J Med 2005; 353: 2643-2653. Go to original source... Go to PubMed...
    54. Charvát J. Ischemická choroba srdeční u diabetiků 1. typu. In: Perušičová J (ed). Diabetes mellitus 1. typu. Praha: Geum 2007: 483-491.
    55. Frye RL, August P, Brooks MM et al. BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-2515. Go to original source... Go to PubMed...
    56. Škrha J. Patofyziologie a patogeneze diabetické neuropatie. Vnitř Lék 2005; 51 (Suppl 1): S67-S72.
    57. Lacigová S, Rušavý Z, Mindlová J et al. Žaludeční vyprazdňování u diabetiků. Vnitř Lék 2000; 46: 213-217. Go to PubMed...
    58. Ziegler D, Zentai CP, Perz S et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population The MONICA/KORA Augsburg Cohort Study. Diabetes Care 2008; 31: 556-561. Go to original source... Go to PubMed...
    59. Bell DS. Dead in bed syndrome - a hypothesis. Diabetes Obes Metab 2006; 8: 261-263. Go to original source... Go to PubMed...
    60. Witte DR, Tesfaye S, Chaturvedi N et al. EURODIAB Prospective Complications Study Group (2005). Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia 2005; 48: 164-171. Go to original source... Go to PubMed...
    61. Ziegler D, Dannehl K, Volksw D et al. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients. Diabetes Care 1992; 15: 908-911. Go to original source... Go to PubMed...
    62. Liao D, Carnethon M, Evans GW et al. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. Diabetes 2002; 51: 3524-3531. Go to original source... Go to PubMed...
    63. Lacigová S, Šafránek P, Čechurová D et al. Could we predict asymptomatic cardiovascular autonomic neuropathy in type 1 diabetic patients attending out-patients clinics? Wien Klin Wochenschr 2007; 119: 303-308. Go to original source... Go to PubMed...
    64. Sallinger J, Vychodil R, Novotný J et al. Telemetric computer-aided system for non-invasive examination of heart rate variability, type VariaPulse TF3. In IEEE Proc Comput Cardiol 1995: 437-440. Go to original source...
    65. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the DCCT. Diabetologia 1998; 41: 416-423. Go to original source... Go to PubMed...
    66. Peterson AD, Rutledge BN, Cleary PA et al. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complication Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care 2007; 30: 2107-2112. Go to original source... Go to PubMed...
    67. Lacigová S, Rušavý Z, Čechurová D et al. Autonomní neuropatie u diabetiků, léčebné možnosti. Vnitř Lék 2002; 48: 534-541. Go to PubMed...
    68. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanism, and therapeutic implications. Endocr Rev 2004; 25: 543-567. Go to original source... Go to PubMed...
    69. Avogaro A, Vigili de Kreutzenberg S, Nedut C et al. Diabetic cardiomyopathy: a metabolic perspective. Am J Cardiol 2004; 93: 13A-16A. Go to original source... Go to PubMed...
    70. Rubler S, Dlugash J, Yuceoglu YZ et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30: 595-602. Go to original source... Go to PubMed...
    71. Spirito P, Bellone P, Harris KM et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-1785. Go to original source... Go to PubMed...
    72. Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham study. JAMA 1979; 241: 2035-2038. Go to original source... Go to PubMed...
    73. Suys BE, Katier N, Roman RP et al. Female children and adolescents with Type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care 2004; 27: 1947-1953. Go to original source... Go to PubMed...
    74. Young LH. Diastolic function and type 1 diabetes. Diabetes Care 2004; 27: 2081-2083. Go to original source... Go to PubMed...
    75. Watts GF, Marwick TH. Ventricular dysfunction in early diabetic heart disease: detection, mechanism and significance. Clin Sci 2003; 105: 537-540. Go to original source... Go to PubMed...
    76. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007; 115: 3213-3222. Go to original source... Go to PubMed...
    77. Dúbrava J. Diabetická kardiomyopatia. Vnitř Lék 2005; 51: 314-319.
    78. How to diagnose diastolic heart failure. Working group report. European Study Group on Diastolic Heart Failure. Eur Heart J 1998; 19: 990-1003. Go to PubMed...
    79. Palmieri V, Capaldo B, Russo C et al. Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. Diabetes Res Clin Pract 2008; 79: 262-268. Go to original source... Go to PubMed...
    80. Marwick TH. Identification of diabetic cardiomyopathy with cardiac magnetic resonance imaging. Int J Cardiovasc Imaging 2006; 22: 91-92. Go to original source... Go to PubMed...
    81. Didangelos TP, Arsos GA, Karamitsos DT et al. Left ventricular systolic and diastolic function in normotensive type 1 diabetic patients with or without autonomic neuropathy. A radionuclide ventriculography study. Diabetes Care 2003; 26: 1955-1960. Go to original source... Go to PubMed...
    82. Lubien E, DeMaria A, Krishnaswamy P et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601. Go to original source... Go to PubMed...
    83. Aepfelbacher FC, Yeon SB, Weinrauch LA et al. Improved glycemic control induces regression of left ventricular mass in patients with type 1 diabetes mellitus. Int J Cardiol 2004; 94: 47-54. Go to original source... Go to PubMed...
    84. Hradec J. Diastolické srdeční selhání. REMEDIA 2004; 14: 121-125.
    85. Lacigová S, Bartunek L, Cechurova D et al. Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with type 1 diabetes. Diabetes Res Clin Pract 2009; 83: 26-31. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.